The American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society have issued new guidance for patients taking semaglutide — the active ingredient in weight loss medications including Ozempic and Wegovy.
American Academy of Ophthalmology issues guidance on weight loss drugs
